China's version of the FDA, or CFDA, announced that it will begin conducting unannounced inspections of medical device companies' manufacturing and development efforts starting Sept. 1, as it looks to step up its oversight of the industry. That means that violations of China's product quality regulations, poor adverse event reporting or complaints of product quality or product safety could trigger an inspection. The inspections could lead to warning letters, investigations or device recalls. More | Here's the official order from the CFDA (in Chinese)